I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 31% ± 8% | |
| glutamatergic neuron | 4 studies | 31% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 31% ± 8% | |
| glutamatergic neuron | 4 studies | 31% ± 12% |
Insufficient scRNA-seq data for expression of BAIAP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 86% | 2315.51 | 210 / 245 | 98% | 20.38 | 490 / 502 |
| brain | 78% | 7572.90 | 2048 / 2642 | 94% | 43.10 | 666 / 705 |
| kidney | 100% | 2150.83 | 89 / 89 | 55% | 6.21 | 499 / 901 |
| pancreas | 76% | 959.77 | 248 / 328 | 75% | 19.26 | 134 / 178 |
| adrenal gland | 58% | 1431.01 | 150 / 258 | 86% | 74.65 | 198 / 230 |
| breast | 85% | 1262.31 | 390 / 459 | 57% | 11.12 | 637 / 1118 |
| liver | 78% | 836.18 | 177 / 226 | 51% | 4.61 | 209 / 406 |
| lung | 77% | 1393.61 | 445 / 578 | 44% | 5.64 | 513 / 1155 |
| spleen | 98% | 1579.08 | 237 / 241 | 0% | 0 | 0 / 0 |
| thymus | 22% | 191.94 | 143 / 653 | 65% | 11.80 | 393 / 605 |
| intestine | 60% | 1125.00 | 579 / 966 | 25% | 2.39 | 130 / 527 |
| bladder | 43% | 486.52 | 9 / 21 | 41% | 5.38 | 208 / 504 |
| stomach | 63% | 663.96 | 225 / 359 | 14% | 1.07 | 41 / 286 |
| eye | 0% | 0 | 0 / 0 | 69% | 8.30 | 55 / 80 |
| adipose | 49% | 449.71 | 584 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 2% | 19.62 | 4 / 180 | 46% | 5.61 | 198 / 430 |
| peripheral blood | 47% | 636.21 | 433 / 929 | 0% | 0 | 0 / 0 |
| uterus | 19% | 522.05 | 33 / 170 | 25% | 3.52 | 116 / 459 |
| skin | 20% | 158.30 | 353 / 1809 | 13% | 1.30 | 61 / 472 |
| esophagus | 17% | 133.54 | 250 / 1445 | 10% | 0.96 | 19 / 183 |
| heart | 20% | 143.69 | 171 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 7% | 58.01 | 90 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.23 | 2 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
| muscle | 1% | 6.77 | 8 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1990502 | Biological process | dense core granule maturation |
| GO_0050795 | Biological process | regulation of behavior |
| GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
| GO_1905413 | Biological process | regulation of dense core granule exocytosis |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0006887 | Biological process | exocytosis |
| GO_0001956 | Biological process | positive regulation of neurotransmitter secretion |
| GO_0032228 | Biological process | regulation of synaptic transmission, GABAergic |
| GO_0098793 | Cellular component | presynapse |
| GO_0031902 | Cellular component | late endosome membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0055038 | Cellular component | recycling endosome membrane |
| GO_0032588 | Cellular component | trans-Golgi network membrane |
| GO_0098982 | Cellular component | GABA-ergic synapse |
| GO_0099503 | Cellular component | secretory vesicle |
| GO_0005829 | Cellular component | cytosol |
| GO_0031045 | Cellular component | dense core granule |
| GO_0005543 | Molecular function | phospholipid binding |
| GO_0000149 | Molecular function | SNARE binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0019905 | Molecular function | syntaxin binding |
| Gene name | BAIAP3 |
| Protein name | BAI1 associated protein 3 BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3) |
| Synonyms | KIAA0734 |
| Description | FUNCTION: Functions in endosome to Golgi retrograde transport. In response to calcium influx, may interact with SNARE fusion receptors and membrane phospholipids to mediate endosome fusion with the trans-Golgi network. By promoting the recycling of secretory vesicle transmembrane proteins, it indirectly controls dense-core secretory vesicle biogenesis, maturation and their ability to mediate the constitutive and regulated secretion of neurotransmitters and hormones. May regulate behavior and food intake by controlling calcium-stimulated exocytosis of neurotransmitters including NPY and serotonin and hormones like insulin . Proposed to play a role in hypothalamic neuronal firing by modulating gamma-aminobutyric acid (GABA)ergic inhibitory neurotransmission (By similarity). . |
| Accessions | A0AA34QW15 A0AA34QVV4 A0AA34QVM4 ENST00000711105.1 A0AA34QVY1 ENST00000711104.1 ENST00000711107.1 ENST00000568887.5 [O94812-5] H3BPP9 ENST00000421665.6 [O94812-7] ENST00000564213.2 ENST00000324385.9 [O94812-1] A0AA34QW16 ENST00000711103.1 A0AA34QVM8 ENST00000562208.5 [O94812-3] O94812 ENST00000397488.6 [O94812-2] ENST00000711109.1 ENST00000711108.1 A0AA34QVV7 ENST00000711110.1 ENST00000561793.2 A0AA34QVM9 A0AA34QVM2 ENST00000711102.1 ENST00000426824.8 [O94812-6] A0AA34QVY3 ENST00000711106.1 |
